Newsletter | June 4, 2025

06.04.25 -- First AMT Program OK'd Under New FDA Designation — Here's What To Know

SPONSOR

Join the 10th Anniversary of the CAR-TCR Summit to reflect on a decade of progress whilst engaging in solutions-driven discussions that will empower you to tackle cell therapy development challenges to help shape the future of the field. You’re guaranteed to leave with actionable solutions to combat the challenges currently halting your therapeutic development and effectively translate your cell therapy from bench to bedside. Register Today - 10% Discount Code: CG10

FOCUS ON REGULATORY & COMPLIANCE

First AMT Program OK'd Under New FDA Designation — Here's What To Know

The FDA's new Advanced Manufacturing Technology program has its first recipient, a development expected to reveal the specific ways the program benefits drug innovators.

Key Strategies For Future-Proofing Gene Therapy Assay Validation

Rigorous validation of immunogenicity assays is crucial for ensuring safety and efficacy, especially in the evolving regulatory landscape. Discover the importance of understanding regulatory standards.

Navigating Global Regulatory Landscapes In An Evolving Biopharma Industry

Minimize regulatory risks and ensure compliance in the evolving biopharma sector. Watch this on-demand discussion for insights on change management and future market trends.

Accelerating Clinical Data Review With Traceable Workflows

Discover how streamlined workflows and enhanced collaboration between data managers and medical reviewers can boost clinical trial efficiency, improve data quality, and ensure patient safety.

Beyond Definitions: The Intricacies Of Cell Therapy Categorization

Understanding the intricacies of cell and gene therapy naming conventions can be confusing but necessary for navigating the development pathway to bring these advanced therapies to market.

EU ANNEX-1 And The Impact Of Contamination Control Strategy On Cleaning

New EU rules tighten grip on contamination control for sterile drugs. Learn how to ensure your cleaning and disinfection meet the stricter standards.

Extractables And Leachables: Setting Up Early For Success With Your CDMO

Discover insights tailored specifically for drug product researchers and manufacturers, offering key knowledge on extractables, leachables, and effective implementation strategies.

Mobile Gowning Cleanroom, Built To Meet ISO 7 Requirements

Uncover how Germfree designed and installed a mobile cGMP cleanroom on a 53′ tractor-trailer chassis to provide a flexible and efficient cleanroom solution tailored to the company’s needs.

Utilize Modular Cleanrooms To Reduce Your Risk Of A Form 483 Violation

Maintaining a cleanroom facility that remains safe for your workers – and where the therapeutics they produce remain safe for patients – can ease your compliance concerns.

4 Considerations For Overcoming Challenges In Gene Therapy Testing

With evolving gene therapy regulations and guidance and limited time during development for testing, here are four points to consider when planning product-release testing of your gene therapy product.

REGULATORY & COMPLIANCE SOLUTIONS

Innovating Unmet Needs For Next-Generation Cellular Immunotherapies - Femtobiomed Inc.

3-Bucket Mopping System - Correct Mopping Protocol - Contec, Inc.

Medical Device Risk Management - Kymanox Corporation

Connect With Cell & Gene: